Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Hindustan Agrigenetics Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Hindustan Agrigenetics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Hind. Agrigeneti - Announcement Under Regulation 30 (LODR)-Updates (Appointment Of Internal Auditor )

    30 May 2026, 6:22PM Announcement Under Regulations 30 (LODR)-Updates (Appointment of Internal Auditor)
  • Hind. Agrigeneti - Non-Applicability Of Disclosure Of Related Party Transactions On A Consolidated Basis For The Half Year En

    30 May 2026, 6:11PM Non-applicability of Disclosure under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements Regulations,2015 -Disclosure of Relate
  • Hind. Agrigeneti - Disclosure Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    30 May 2026, 5:48PM Disclosure under Regulation 32 of SEBI (Listing obligations and Disclosure Requirements) Regulations,2015-Statement of Deviation(s) or Variation(s)
  • Hind. Agrigeneti - Results-Financial Results For 03-31-2026

    30 May 2026, 5:24PM Results-Financials Results for 03-31-2026
  • Hind. Agrigeneti - Board Meeting Outcome for Outcome Of The Board Meeting As Per Regulation 30, SEBI (Listing Obligation And\

    30 May 2026, 4:51PM Outcome of the Board Meeting as per Regulation 30, SEBI (Listing Obligation and\r\ndisclosure Requirements) Regulations, 2015
  • Hind. Agrigeneti - Board Meeting Intimation for To Consider And Approve The Audited Financial Results Of The Company For The

    21 May 2026, 4:23PM Hindustan Agrigenetics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consid
  • Hind. Agrigeneti has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    20 Apr 2026, 5:40PM As of March 2026, 25.35% is owned by Indian Promoters and 74.65% by Public. <p align=justify> Top five Promoters holding highest number of shares of H
  • Hind. Agrigeneti - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    11 Apr 2026, 6:32PM CERTIFICATE UNDER REGULATION 74(5) OF THE SECURITIES AND EXCHANGE BOARD OF INDIA(DEPOSITORY AND PARTICIPANTS) REGULATIONS, 2018 FOR THE QUATAR ENDED 3
  • Hind. Agrigeneti - Submission Regarding The Typographical Error In Relation To The Intimation Dated 14.03.2026

    16 Mar 2026, 6:18PM This is to inform you that the intimation regarding the appointment of Mr. Suresh Srinivasan, the CFO dated 14th March, 2026 was filed with an error i
  • Hind. Agrigeneti - Announcement under Regulation 30 (LODR)-Change in Management Control

    14 Mar 2026, 4:52PM The Appointment of MR. Sursh Srinivasan as Chief Financial officer (CFO) And Key Managerial Personnel (KMP) of the Company with effect from 16th March
  • Hind. Agrigeneti - Board Meeting Outcome for The Board Of Directors Of The Company In Its Meeting Held On 14Th March 2026 Has

    14 Mar 2026, 4:30PM The Board of Directors of the Company in its meeting held on 14th March 2026 has considered\r\nand approved the Appointment of Chief Financial Officer

Key fundamentals

Evaluate the intrinsic value of Hindustan Agrigenetics Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 12.1576 12.0234 12.3285 11.859 2.001
Liabilities 12.1576 12.0234 12.3285 11.859 2.001
Equity 4.4002 4.4002 4.4002 4.4002 4.4002
Gross Profit -0.8357 -0.264 0.6426 9.9099 -0.1082
Net Profit 0.1342 -0.3051 0.4694 9.8579 -0.097
Cash From Operating Activities 0.5233 0.073 -0.4213 -6.5152 5.1684
NPM(%) 309.93 -36.45 45.44 91.71 -76.62
Revenue 0.0433 0.837 1.033 10.7484 0.1266
Expenses 0.879 1.101 0.3904 0.8384 0.2348
ROE(%) 1.1 -2.5 3.86 81.08 -0.79

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Hindustan Agrigenetics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
GRM Overseas Ltd 90.30 -8.32 25.29 274.68 179.39 0.00
Jain Irrigation Systems Ltd 30.11 -2.46 0.00 3163.95 -17.22 0.00
Tierra Agrotech Ltd 40.89 0.59 0.00 300.29 -7.60 0.00
Kohinoor Foods Ltd 23.20 -2.93 1.08 169.71 217.58 0.00

Company Info

Hindustan Agrigencies Limited (HAL) was incorporated on 25.07.90 with the Registrar of Companies, Delhi & Haryana as a private limited company with its registered office in New Delhi and converted into a public limited Company on 19.02.94 and obtained the fresh certificate of incorporation on 16.05.1994 with the objective of positioning itself in the sunrise industry of agriculture biotechnology. The Company commenced implementation of a tissue culture and hybrid seeds project at Hyderabad with a capital outlay of Rs.106 Iakhs in 1990, with venture capital assistance of Rs.80 lakhs as Term Loan & Rs.6.5 lacs as equity capital from PCTC. After trial production in early 1992, commercial production of hybrid seeds was started in April 1992. At the same time the tissue culture project implementation and development of mother cultures were in progress. The tissue culture development work has been completed and trial exports have been successful. Commercial production of tissue culture plantlets commenced in August 1994. PRESENT BUSINESS The Company has set up a Tissue Culture & Hybrid Seeds Project having an installed capacity of 3000 TPA of hybrid seeds and 2 million tissue culture plantlets per annum. The Company has availed working capital limits of Rs.70 lakhs from State Bank of Hyderabad. HYBRID SEEDS is a technology driven business. Development of superior hybrids through R&D is a pre-requisite for success. A strong extention and field promotion programme is necessary to transfer the technology from lab to land. Trial production of seeds started in early 1992 and commercial production started from April 1992. Simultaneously research work on seeds was started. Using the experience and expertise of Company's research staff, it developed and introduced its own research hybrids in record time. The company today has proprietory hybrids in 6 crops viz Sunflower, Cotton, Jowar, Bajra, Fodder Jowar and Tomato. The Company's products (under the brand name "Supergene" and "Sahakar") are now recognised as quality seeds and are compared with those of large and established companies in the industry. The Company is operating in 9 states, the major markets being Maharashtra, Karnataka, Punjab, Haryana and Rajasthan. The Company has a network of dealers in these states. The distribution is carried out through distributors located in district headquarters or preferred dealers located in mandi towns. They in turn, distribute the Company's seeds to retailers who further sell them to the farmers. The sale of Company's seeds is almost exclusively through private channels except for supplies made to government departments or state seed corporation. TISSUE CULTURE is a technology for cloning of plants. Success in tissue culture business requires access to 'elite clones' and having commercially viable technology for high multiplication rates. A glass house is registered for hardening in-vitro plants. Tissue culture business is of recent origin in India. It involves exporting ornamental plants to the West. There is also a large market for horticulture plants like banana, strawberries and forestry in India. The Company has successfully developed indigenous technology for producing different varieties of ornamental plants like syngonium, orchids, chrysanthemum, spathyphylum, etc, and horticulture plants like strawberry, grapes, and bananas through tissue culture techniques. These products are presently under test marketing. Trial consignments have already been exported to parties in Spain, Belgium, Holland and USA from whom favourable feedback has been received. The commercial sales of plantlets developed through tissue culture commenced in August 1994. MAIN OBJECTS OF THE COMPANY The main objects of the Company as set out in Memorandum and Articles of Association of the Company are: 1) To establish and carry on the business as researchers, developers, traders, dealers, agents, importers, exporters, distributors, representatives or otherwise in respect of the following products: a) Know-how, patents and products of biotechnology and genetic engineering, research and development in the field of agriculture, tissue culture and its metabolites, aquaculture, sericulture, pisciculture and marine, animal and other produce covered and understood by the term agriculture. b) Products which serve as any type of agricultural input such as pesticides (biological or chemical or any other type), fertilisers, nutrients, seeds, feeds, weedicides, fungicides and implements used for agriculture and agricultural outputs processed or other wise. 2) To establish, maintain, conduct and operate research establishments, centres for dissemination of knowledge and technical advisory service for the purposes of agriculture in particular and biology and other frontiers of science with a view of evaluating, developing, improving, modifying or discovering new agricultural inputs. SUBSIDIARIES There are no companies which are subsidiary to this company and the promoters have not promoted any other company.

Hindustan Agrigencies Limited (HAL) was incorporated on 25.07.90 with the Registrar of Companies, Delhi & Haryana as a private limited company with its registered office in New Delhi and converted into a public limited Company on 19.02.94 and obtained the fresh certificate of incorporation on 16.05.1994 with the objective of positioning itself in the sunrise industry of agriculture biotechnology. The Company commenced implementation of a tissue culture and hybrid seeds project at Hyderabad with a capital outlay of Rs.106 Iakhs in 1990, with venture capital assistance of Rs.80 lakhs as Term Loan & Rs.6.5 lacs as equity capital from PCTC. After trial production in early 1992, commercial production of hybrid seeds was started in April 1992. At the same time the tissue culture project implementation and development of mother cultures were in progress. The tissue culture development work has been completed and trial exports have been successful. Commercial production of tissue culture plantlets commenced in August 1994. PRESENT BUSINESS The Company has set up a Tissue Culture & Hybrid Seeds Project having an installed capacity of 3000 TPA of hybrid seeds and 2 million tissue culture plantlets per annum. The Company has availed working capital limits of Rs.70 lakhs from State Bank of Hyderabad. HYBRID SEEDS is a technology driven business. Development of superior hybrids through R&D is a pre-requisite for success. A strong extention and field promotion programme is necessary to transfer the technology from lab to land. Trial production of seeds started in early 1992 and commercial production started from April 1992. Simultaneously research work on seeds was started. Using the experience and expertise of Company's research staff, it developed and introduced its own research hybrids in record time. The company today has proprietory hybrids in 6 crops viz Sunflower, Cotton, Jowar, Bajra, Fodder Jowar and Tomato. The Company's products (under the brand name "Supergene" and "Sahakar") are now recognised as quality seeds and are compared with those of large and established companies in the industry. The Company is operating in 9 states, the major markets being Maharashtra, Karnataka, Punjab, Haryana and Rajasthan. The Company has a network of dealers in these states. The distribution is carried out through distributors located in district headquarters or preferred dealers located in mandi towns. They in turn, distribute the Company's seeds to retailers who further sell them to the farmers. The sale of Company's seeds is almost exclusively through private channels except for supplies made to government departments or state seed corporation. TISSUE CULTURE is a technology for cloning of plants. Success in tissue culture business requires access to 'elite clones' and having commercially viable technology for high multiplication rates. A glass house is registered for hardening in-vitro plants. Tissue culture business is of recent origin in India. It involves exporting ornamental plants to the West. There is also a large market for horticulture plants like banana, strawberries and forestry in India. The Company has successfully developed indigenous technology for producing different varieties of ornamental plants like syngonium, orchids, chrysanthemum, spathyphylum, etc, and horticulture plants like strawberry, grapes, and bananas through tissue culture techniques. These products are presently under test marketing. Trial consignments have already been exported to parties in Spain, Belgium, Holland and USA from whom favourable feedback has been received. The commercial sales of plantlets developed through tissue culture commenced in August 1994. MAIN OBJECTS OF THE COMPANY The main objects of the Company as set out in Memorandum and Articles of Association of the Company are: 1) To establish and carry on the business as researchers, developers, traders, dealers, agents, importers, exporters, distributors, representatives or otherwise in respect of the following products: a) Know-how, patents and products of biotechnology and genetic engineering, research and development in the field of agriculture, tissue culture and its metabolites, aquaculture, sericulture, pisciculture and marine, animal and other produce covered and understood by the term agriculture. b) Products which serve as any type of agricultural input such as pesticides (biological or chemical or any other type), fertilisers, nutrients, seeds, feeds, weedicides, fungicides and implements used for agriculture and agricultural outputs processed or other wise. 2) To establish, maintain, conduct and operate research establishments, centres for dissemination of knowledge and technical advisory service for the purposes of agriculture in particular and biology and other frontiers of science with a view of evaluating, developing, improving, modifying or discovering new agricultural inputs. SUBSIDIARIES There are no companies which are subsidiary to this company and the promoters have not promoted any other company.

Read More

Parent Organisation

Hindustan Agrigenetics Ltd.

Founded

25/07/1990

Managing Director

Mr.Pranav Kapur

NSE Symbol

FAQ

The current price of Hindustan Agrigenetics Ltd is

The 52-week high for Hindustan Agrigenetics Ltd is

The market capitalization of Hindustan Agrigenetics Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Hindustan Agrigenetics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Hindustan Agrigenetics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Hindustan Agrigenetics Ltd shares.

The CEO of Hindustan Agrigenetics Ltd is Mr.Pranav Kapur, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT